ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
14 juin 2022 02h05 HE
|
ResMed Inc.
Acquisition creates a global leader in out-of-hospital software solutionsAccelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in...
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
07 juin 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global...
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
01 juin 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock...
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
25 mai 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic...
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
18 mai 2022 16h05 HE
|
ResMed Inc.
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE...
ResMed Announces Leadership Change
05 mai 2022 16h05 HE
|
ResMed Inc.
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
28 avr. 2022 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
27 avr. 2022 16h05 HE
|
ResMed Inc.
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on...
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
07 avr. 2022 16h05 HE
|
ResMed Inc.
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on...
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
17 mars 2022 16h05 HE
|
ResMed Inc.
SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital...